Log in to save to my catalogue

Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and co...

Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and co...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6462009

Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection

About this item

Full title

Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection

Publisher

London: Nature Publishing Group UK

Journal title

Cell research, 2019-04, Vol.29 (4), p.313-329

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Missense mutations in
Leucine-Rich Repeat Kinase 2
(LRRK2) cause the majority of familial and some sporadic forms of Parkinson’s disease (PD). The hyperactivity of LRRK2 kinase induced by the pathogenic mutations underlies neurotoxicity, promoting the development of LRRK2 kinase inhibitors as therapeutics. Many potent and specific small-molec...

Alternative Titles

Full title

Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6462009

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6462009

Other Identifiers

ISSN

1001-0602,1748-7838

E-ISSN

1748-7838

DOI

10.1038/s41422-019-0153-8

How to access this item